Panda Sagarika, Dash Abhilash, Chhotray Pritam, Nayak Biswajit, Mouli Tatikonda Chandra, Mishra Shakti Bedanta
Department of Critical Care Medicine, IMS and SUM Hospital, Bhubaneswar, Odisha, India.
Department of Respiratory Medicine, IMS and SUM Hospital, Bhubaneswar, Odisha, India.
Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):217-221. doi: 10.4103/ijciis.ijciis_34_22. Epub 2022 Dec 26.
Carbapenem-resistant Enterobacteriaceae, especially , have become a severe global problem with a significant threat to public health, but few studies have investigated the risk factors and epidemiology of carbapenem-resistant (CRKP) infections in India.
We performed a retrospective observational study of 224 participants with who were admitted to the medical intensive care unit (ICU) of Institute of Medical Sciences and SUM Hospital, Bhubaneswar, India, between January 1 and December 30, 2020. Antibiotic susceptibility testing was done by automated broth microdilution VITEK 2 (BioMerieux, Inc., Hazelwood, USA). The Clinical and Laboratory Standards Institute document M100-S22 (January 2020) was used to interpret antimicrobial susceptibility testing. Data were obtained from paper medical records.
Two hundred and twenty-four subjects with culture-positive for were retrieved during the study period, out of which 108 had CRKP. The risk factors for univariate analysis were Acute Physiology and Chronic Health Evaluation II, ICU length of stay (LOS), invasive mechanical ventilator days, central venous catheter days, and arterial line days. The multivariate analysis showed invasive mechanical ventilation and ICU LOS were independent risk factors for CRKP infection. Mortality in the CRKP group was 48 (44%) compared to 27 (23%) in the carbapenem-sensitive (CSKP) group, which was statistically significant ( < 0.01).
Infection due to CRKP in the ICU was associated with 1.9 times higher mortality as compared to CSKP. Invasive mechanical ventilation and ICU LOS were found to be independent risk factors for CRKP infection.
耐碳青霉烯类肠杆菌科细菌,尤其是[具体细菌名称未给出],已成为一个严重的全球问题,对公众健康构成重大威胁,但在印度,很少有研究调查耐碳青霉烯类[具体细菌名称未给出](CRKP)感染的危险因素和流行病学情况。
我们对2020年1月1日至12月30日期间入住印度布巴内斯瓦尔医学科学研究所和SUM医院重症监护病房(ICU)的224例[具体细菌名称未给出]患者进行了一项回顾性观察研究。采用自动化肉汤微量稀释法VITEK 2(美国密苏里州黑兹尔伍德的生物梅里埃公司)进行药敏试验。使用临床和实验室标准协会文件M100 - S22(2020年1月)解释药敏试验结果。数据从纸质病历中获取。
在研究期间共检索到224例[具体细菌名称未给出]培养阳性的受试者,其中108例为CRKP。单因素分析的危险因素包括急性生理与慢性健康状况评分系统II、ICU住院时间(LOS)、有创机械通气天数、中心静脉导管留置天数和动脉导管留置天数。多因素分析显示,有创机械通气和ICU住院时间是CRKP感染的独立危险因素。CRKP组的死亡率为48例(44%),而碳青霉烯类敏感[具体细菌名称未给出](CSKP)组为27例(23%),差异有统计学意义(P < 0.01)。
ICU中CRKP感染导致的死亡率比CSKP感染高1.9倍。有创机械通气和ICU住院时间是CRKP感染的独立危险因素。